liver disease chronic liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who are 18 years of age or older at the time of enrollment (2) Patients diagnosed with chronic liver disease by blood test or imaging test (3) Patients who give written consent to participate in this study (4) Patients with any type of background liver disease.
Exclusion criteria
Exclusion criteria: (1) Pregnant, lactating, or possibly pregnant patients (2) Other patients who are judged to be inappropriate by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of diagnostic performance of conventional FS and SmartExam FS for liver steatosis using MRI-PDFF as reference | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Comparison of diagnostic performance of conventional FibroScan and SmartExam-equipped FibroScan in liver fibrosis (MRE) 2.Comparison of diagnostic performance of conventional FibroScan and SmartExam-equipped FibroScan for liver fibrosis (pathological findings) 3.Comparison of diagnostic performance of conventional FibroScan and SmartExam-equipped FibroScan in liver steatosis (pathological findings) 4.Comparison of variation in liver steatosis measurement results between the conventional FibroScan and the SmartExam-equipped FibroScan 5.Comparison of variation in liver stiffness measurement results between the conventional FibroScan and the SmartExam-equipped FibroScan 6. Correlation of liver sfiffness measurement results obtained by the conventional FibroScan and the SmartExam-equipped FibroScan 7. Correlation of liver stetosis measurement results between conventional FibroScan and SmartExam-equipped FibroScan Translated with www.DeepL.com/Translator (free version) | — |
Contacts
Yokohama City University Graduate School of Medicine